Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

A phenotypic signature that identifies neoantigen-reactive T cells in fresh human lung cancers

21 Apr 2022

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cancer Immunotherapy and Biomarkers
Share to CAR-T cell therapy research
Share to Immunotherapy and Immune Responses

Source

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Identifiers

PMID: 35452604
DOI: 10.1016/j.ccell.2022.03.012

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

A phenotypic signature that identifies neoantigen-reactive T cells in fresh human lung cancersPMID 35452604Read ↗

The Current Lung Cancer Neoantigen Landscape and Implications for Therapy.Semantic proximity Read ↗

Phenotypic signatures of circulating neoantigen-reactive CD8+ T cells in patients with metastatic cancersSemantic proximity Read ↗

Neoantigen-Based Immunotherapy in Lung Cancer: Advances, Challenges and ProspectsSemantic proximity Read ↗

Neoantigens in Cancer Immunotherapy: An Overview with a Focus on Non-small Cell Lung Cancer and Pancreatic Ductal Adenocarcinoma.Semantic proximity Read ↗

Identification of neoantigens for individualized therapeutic cancer vaccinesSemantic proximity Read ↗

Transcriptomic profiles of neoantigen-reactive T cells in human gastrointestinal cancersSemantic proximity Read ↗

Neoantigen reactive T cells correlate with the low mutational burden in hematological malignancies.Semantic proximity Read ↗

Mapping the landscape of T cell-recognized neoantigens in cancer patients.Semantic proximity Read ↗

Impaired Cytolytic Activity and Loss of Clonal Neoantigens in Elderly Patients With Lung AdenocarcinomaSemantic proximity Read ↗

Neoantigens encoded in the cancer genomeSemantic proximity Read ↗

Targeting neoantigens for cancer immunotherapy: Table 1.Semantic proximity Read ↗

Endogenous CD4+ T Cells Recognize Neoantigens in Lung Cancer Patients, Including Recurrent Oncogenic KRAS and ERBB2 ( Her2 ) Driver MutationsSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.